Thank you to our sponsors and contributors
To be announced
CSL Seqirus is part of CSL (ASX: CSL). As a global leader in the protection of public health and one of the largest influenza vaccine providers in the world, CSL Seqirus is committed to preventing infectious diseases, like influenza and COVID-19, and is a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, and leading R&D capabilities, CSL Seqirus offers a broad portfolio of innovative, differentiated vaccines in more than 20 countries around the world.
Founded in 2009 in Siena, Italy, VisMederi is an independent research organization committed to advancing global health. We provide high-quality analytical services, clinical trial support, and cutting-edge research in vaccines and pharmaceuticals, aiming to develop safer, more effective medicines.
Guided by quality, innovation, and integrity, we partner with pharmaceutical companies, research institutions, and global health organizations. Our expertise includes vaccine R&D, bioanalytical testing, and comprehensive clinical trial support (phases II–IV), all compliant with EMA, FDA, and PMDA standards.
Certified ISO 9001 and accredited by Accredia, our data is recognized internationally. As part of the CEPI centralized laboratory network, we contribute to global epidemic preparedness.
From university spin-off to Financial Times FT 1000 recognition, VisMederi continues to grow, investing in advanced technologies to stay at the forefront of science. Our mission: deliver reliable results that help build a healthier future.
